NCOA3 and cancer: Therefore, SMIs that can disrupt SRC-3 function should simultaneously prevent the activation of such a large breadth of growth pathways that underlie critical steps in cancer initiation, expansion, metastasis, and chemoresistance, that the cancer cell would be less able to overcome resistance to a SRC-3 SMI.